Cargando…
Agreement between dried blood spots and HemoCue in Tamil Nadu, India
India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085154/ https://www.ncbi.nlm.nih.gov/pubmed/33927229 http://dx.doi.org/10.1038/s41598-021-88425-y |
_version_ | 1783686277350031360 |
---|---|
author | Roshania, Reshma P. Mehta, Rukshan V. Shete, Ashwini Bingewar, Rohini Kulkarni, Sangeeta Mahajan, Aprajit Miller, Grant Tarozzi, Alessandro Martorell, Reynaldo |
author_facet | Roshania, Reshma P. Mehta, Rukshan V. Shete, Ashwini Bingewar, Rohini Kulkarni, Sangeeta Mahajan, Aprajit Miller, Grant Tarozzi, Alessandro Martorell, Reynaldo |
author_sort | Roshania, Reshma P. |
collection | PubMed |
description | India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device most widely used for large-scale surveys. The use of dried blood spots (DBS) to assess hemoglobin (Hb) concentration is a potential alternative, particularly in field settings. The objective of this study is to assess Hb measurement agreement between capillary HemoCue and DBS among two age groups, children 6–59 months and females age 12–40 years. We analyzed data from the baseline round of a cluster randomized rice fortification intervention in Cuddalore district of Tamil Nadu, India. Capillary blood was collected from a subset of participants for Hb assessment by HemoCue 301 and DBS methods. We calculated Lin’s concordance correlation coefficient, and tested bias by conducting paired t-tests of Hb concentration. Independence of the bias and Hb magnitude was examined visually using Bland–Altman plots and statistically tested by Pearson’s correlation. We assessed differences in anemia classification using McNemar’s test of marginal homogeneity. Concordance between HemoCue and DBS Hb measures was moderate for both children 6–59 months (ρ(c) = 0.67; 95% CI 0.65, 0.71) and females 12–40 years (ρ(c) = 0.67: 95% CI 0.64, 0.69). HemoCue measures were on average 0.06 g/dL higher than DBS for children (95% CI 0.002, 0.12; p = 0.043) and 0.29 g/dL lower than DBS for females (95% CI − 0.34, − 0.23; p < 0.0001). 50% and 56% of children were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). 55% and 47% of females were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). There is moderate statistical agreement of Hb concentration between HemoCue and DBS for both age groups. The choice of Hb assessment method has important implications for individual anemia diagnosis and population prevalence estimates. Further research is required to understand factors that influence the accuracy and reliability of DBS as a methodology for Hb assessment. |
format | Online Article Text |
id | pubmed-8085154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80851542021-05-03 Agreement between dried blood spots and HemoCue in Tamil Nadu, India Roshania, Reshma P. Mehta, Rukshan V. Shete, Ashwini Bingewar, Rohini Kulkarni, Sangeeta Mahajan, Aprajit Miller, Grant Tarozzi, Alessandro Martorell, Reynaldo Sci Rep Article India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device most widely used for large-scale surveys. The use of dried blood spots (DBS) to assess hemoglobin (Hb) concentration is a potential alternative, particularly in field settings. The objective of this study is to assess Hb measurement agreement between capillary HemoCue and DBS among two age groups, children 6–59 months and females age 12–40 years. We analyzed data from the baseline round of a cluster randomized rice fortification intervention in Cuddalore district of Tamil Nadu, India. Capillary blood was collected from a subset of participants for Hb assessment by HemoCue 301 and DBS methods. We calculated Lin’s concordance correlation coefficient, and tested bias by conducting paired t-tests of Hb concentration. Independence of the bias and Hb magnitude was examined visually using Bland–Altman plots and statistically tested by Pearson’s correlation. We assessed differences in anemia classification using McNemar’s test of marginal homogeneity. Concordance between HemoCue and DBS Hb measures was moderate for both children 6–59 months (ρ(c) = 0.67; 95% CI 0.65, 0.71) and females 12–40 years (ρ(c) = 0.67: 95% CI 0.64, 0.69). HemoCue measures were on average 0.06 g/dL higher than DBS for children (95% CI 0.002, 0.12; p = 0.043) and 0.29 g/dL lower than DBS for females (95% CI − 0.34, − 0.23; p < 0.0001). 50% and 56% of children were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). 55% and 47% of females were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). There is moderate statistical agreement of Hb concentration between HemoCue and DBS for both age groups. The choice of Hb assessment method has important implications for individual anemia diagnosis and population prevalence estimates. Further research is required to understand factors that influence the accuracy and reliability of DBS as a methodology for Hb assessment. Nature Publishing Group UK 2021-04-29 /pmc/articles/PMC8085154/ /pubmed/33927229 http://dx.doi.org/10.1038/s41598-021-88425-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Roshania, Reshma P. Mehta, Rukshan V. Shete, Ashwini Bingewar, Rohini Kulkarni, Sangeeta Mahajan, Aprajit Miller, Grant Tarozzi, Alessandro Martorell, Reynaldo Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title | Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title_full | Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title_fullStr | Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title_full_unstemmed | Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title_short | Agreement between dried blood spots and HemoCue in Tamil Nadu, India |
title_sort | agreement between dried blood spots and hemocue in tamil nadu, india |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085154/ https://www.ncbi.nlm.nih.gov/pubmed/33927229 http://dx.doi.org/10.1038/s41598-021-88425-y |
work_keys_str_mv | AT roshaniareshmap agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT mehtarukshanv agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT sheteashwini agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT bingewarrohini agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT kulkarnisangeeta agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT mahajanaprajit agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT millergrant agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT tarozzialessandro agreementbetweendriedbloodspotsandhemocueintamilnaduindia AT martorellreynaldo agreementbetweendriedbloodspotsandhemocueintamilnaduindia |